CAUWENBERGH GEERT 4
4 · RXi Pharmaceuticals Corp · Filed Oct 15, 2018
Insider Transaction Report
Form 4
CAUWENBERGH GEERT
DirectorPresident & CEO
Transactions
- Award
Common stock, $0.0001 par value
2018-10-12$0.47/sh+17,230$8,096→ 126,075 total
Holdings
- 450(indirect: By Spouse)
Common stock, $0.0001 par value
Footnotes (1)
- [F1]As reported on a Current Report on Form 8-K filed on September 4, 2018, the reporting person has elected to receive a portion of his compensation in stock in lieu of cash. Accordingly, on October 12, 2018, the reporting person received a total of 17,230 shares of common stock from the Company in lieu of $8,096.16 of cash compensation, which includes base salary, that was payable on such date.